Guangzhou Kingmed Diagnostics Group Co Ltd
SSE:603882
Intrinsic Value
Guangzhou Kingmed Diagnostics Group Co., Ltd. engages in the provision of outsourced medical examination and pathological diagnosis services to medical institutions. [ Read More ]
The intrinsic value of one
Guangzhou Kingmed Diagnostics Group Co Ltd
stock under the Base Case scenario is
64.37
CNY.
Compared to the current market price of 45.85 CNY,
Guangzhou Kingmed Diagnostics Group Co Ltd
is
Undervalued by 29%.
Guangzhou Kingmed Diagnostics Group Co Ltd's market capitalization is 21.5B CNY.
Guangzhou Kingmed Diagnostics Group Co Ltd stock price is 45.85 CNY.
Guangzhou Kingmed Diagnostics Group Co Ltd stock price (45.85 CNY) is 29% less than its Intrinsic Value (64.37 CNY).
Guangzhou Kingmed Diagnostics Group Co Ltd stock price (45.85 CNY) is 21% less than its DCF Value (58.29 CNY). Open DCF Valuation
Guangzhou Kingmed Diagnostics Group Co Ltd stock price (45.85 CNY) is 35% less than its Relative Value (70.45 CNY). Open Relative Valuation
Guangzhou Kingmed Diagnostics Group Co Ltd has upside potential of 81% compared to the average analyst price target.
Open Wall St Estimates
Guangzhou Kingmed Diagnostics Group Co Ltd's ROE (Return on Equity) for the past 12 months is positive and is equal to 10%.
Guangzhou Kingmed Diagnostics Group Co Ltd's ROIC (Return on Invested Capital) for the past 12 months is positive and is equal to 8%.
Guangzhou Kingmed Diagnostics Group Co Ltd has positive Net Income for the last twelve months.
Guangzhou Kingmed Diagnostics Group Co Ltd's Revenue has been growing by 10% per year for the last 3 years.
Guangzhou Kingmed Diagnostics Group Co Ltd's Revenue is forecast to fall at a rate of 7% per year over the next 3 years.
Guangzhou Kingmed Diagnostics Group Co Ltd has positive Operating Income for the last twelve months.
Guangzhou Kingmed Diagnostics Group Co Ltd has positive Free Cash Flow for the last twelve months.
Guangzhou Kingmed Diagnostics Group Co Ltd's Revenue has dropped by 38% over the past 12 months.
Guangzhou Kingmed Diagnostics Group Co Ltd's ROE (Return on Equity) has significantly decreased in the last 3 years from 59% to 10%.
Guangzhou Kingmed Diagnostics Group Co Ltd's ROIC (Return on Invested Capital) has significantly decreased in the last 3 years from 61% to 8%.
Guangzhou Kingmed Diagnostics Group Co Ltd has positive Gross Profit for the last twelve months.
Guangzhou Kingmed Diagnostics Group Co Ltd's short-term assets (9B CNY) exceed its short-term liabilties (3B CNY).
Guangzhou Kingmed Diagnostics Group Co Ltd has very high three-year average ROE (Return on Equity): 40%. The company is very efficient at transforming stockholders' equity into net income.
Guangzhou Kingmed Diagnostics Group Co Ltd's long-term assets (12B CNY) exceed its long-term liabilties (4B CNY).
Guangzhou Kingmed Diagnostics Group Co Ltd has very high three-year average ROIC (Return on Invested Capital): 43%. The company is very efficient at using invested capital to generate operating income.
Guangzhou Kingmed Diagnostics Group Co Ltd's D/E (Debt to Equity) is very low and is equal to 0.05.
Guangzhou Kingmed Diagnostics Group Co Ltd has negative Net Debt. This means that the company has more cash and short-term investments (2B CNY) than debt (448m CNY).
Guangzhou Kingmed Diagnostics Group Co Ltd's Altman Z-Score is very high and is equal to 6.83.
Valuation Backtest
Guangzhou Kingmed Diagnostics Group Co Ltd
Run backtest to discover the historical profit from buying and selling
Guangzhou Kingmed Diagnostics Group Co Ltd
stocks based on their intrinsic value.
Analyze the historical link between intrinsic value and market price to make more informed investment decisions.
Fundamental Analysis
Guangzhou Kingmed Diagnostics Group Co Ltd
Balance Sheet Decomposition
Guangzhou Kingmed Diagnostics Group Co Ltd
| Current Assets | 8.6B |
| Cash & Short-Term Investments | 2.1B |
| Receivables | 6.2B |
| Other Current Assets | 353.2m |
| Non-Current Assets | 3.6B |
| Long-Term Investments | 584.5m |
| PP&E | 2.3B |
| Intangibles | 202.9m |
| Other Non-Current Assets | 448.4m |
| Current Liabilities | 2.9B |
| Accounts Payable | 2.2B |
| Accrued Liabilities | 268.6m |
| Short-Term Debt | 1m |
| Other Current Liabilities | 495m |
| Non-Current Liabilities | 740.6m |
| Long-Term Debt | 447.2m |
| Other Non-Current Liabilities | 293.4m |
Earnings Waterfall
Guangzhou Kingmed Diagnostics Group Co Ltd
|
Revenue
|
9.6B
CNY
|
|
Cost of Revenue
|
-6B
CNY
|
|
Gross Profit
|
3.6B
CNY
|
|
Operating Expenses
|
-2.8B
CNY
|
|
Operating Income
|
716.9m
CNY
|
|
Other Expenses
|
163.6m
CNY
|
|
Net Income
|
880.5m
CNY
|
Free Cash Flow Analysis
Guangzhou Kingmed Diagnostics Group Co Ltd
What is Free Cash Flow?
Profitability Score
Profitability Due Diligence
Guangzhou Kingmed Diagnostics Group Co Ltd's profitability score is 60/100. The higher the profitability score, the more profitable the company is.
Score
Guangzhou Kingmed Diagnostics Group Co Ltd's profitability score is 60/100. The higher the profitability score, the more profitable the company is.
Solvency Score
Solvency Due Diligence
Guangzhou Kingmed Diagnostics Group Co Ltd's solvency score is 83/100. The higher the solvency score, the more solvent the company is.
Score
Guangzhou Kingmed Diagnostics Group Co Ltd's solvency score is 83/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
Price Targets Summary
Guangzhou Kingmed Diagnostics Group Co Ltd
According to Wall Street analysts, the average 1-year price target for
Guangzhou Kingmed Diagnostics Group Co Ltd
is 83.08 CNY
with a low forecast of 70.66 CNY and a high forecast of 103.49 CNY.
Shareholder Return
Price
Guangzhou Kingmed Diagnostics Group Co Ltd
| Average Annual Return | 43.67% |
| Standard Deviation of Annual Returns | 84.62% |
| Max Drawdown | -73% |
| Market Capitalization | 21.5B CNY |
| Shares Outstanding | 468 771 000 |
| Percentage of Shares Shorted |
N/A
|
Company Profile
Guangzhou Kingmed Diagnostics Group Co Ltd
Country
Industry
Market Cap
Dividend Yield
Description
Guangzhou Kingmed Diagnostics Group Co., Ltd. engages in the provision of outsourced medical examination and pathological diagnosis services to medical institutions. The company is headquartered in Guangzhou, Guangdong and currently employs 12,371 full-time employees. The company went IPO on 2017-09-08. The firm is also engaged in other businesses, including sales of diagnostic products, provision of physical examination and cold chain logistics services.
Contact
IPO
Employees
Officers
The intrinsic value of one
Guangzhou Kingmed Diagnostics Group Co Ltd
stock under the Base Case scenario is
64.37
CNY.
Compared to the current market price of 45.85 CNY,
Guangzhou Kingmed Diagnostics Group Co Ltd
is
Undervalued by 29%.
You don't have any saved screeners yet
